Last year their letter, in which they said the would analyze data collected on Omontys, started a short attack on Affymax. I believe it said it would take a few weeks. This letter from Feb14,2013 was of such great importance it had to be submitted to the SEC. Where are the results of that analysis? If they need tabulations run I'm available send me the files.
As always I have to ask.
How many CKD patients on Dialysis have died at dialysis centers since the Omontys recall? Now what drug would be suspected if indeed there have been deaths in that population. And if so has it been pulled off the market. From the lack of news of other drugs being pulled the answer must be zero. I believe those who embraced the SA articles on the FAERs data and used it as proof of why Omontys could not be returned should provide an update to prove their thesis don't you. They'll have a full year of data, show us. Prove you're not frauds.
Maybe TAkeda purposely wait for 1 year to ask same question ,who knows maybe they are investigation DEATHs after pulled O from the market...How many patient died from other drugs during One year?..these questions should answer from authorities ...
I was asking same question about how many suffered without of getting O last summer. No one responded. I believe it is a lot more patients got hurt without O than those who died because of reaction. They have a simplest way to use O subcutaneous only, while T keep their investigations. It is possible. And nobody doing that...Question